Market Overview

UPDATE: Piper Jaffray Downgrades Allscripts Healthcare Solutions to Underweight on Weak Results

Share:
Related MDRX
Cookeville Medical Center Selects Allscripts for Chronic Care Management (CCM) Program
Allscripts Partners With CoverMyMeds to Help Patients Fill Prescriptions Faster

Piper Jaffray reduced its rating on Allscripts Healthcare Solutions (NASDAQ: MDRX) from Neutral to Underweight and lowered its price target from $12 to $7.

Piper Jaffray commented, "We are downgrading to UW given bookings are accelerating downward, margins are going nowhere, and the Company attempts to integrate a portfolio of outdated products while embarking on an ambitious release cycle of new products. About the best one can hope for from here is a takeout, which we still don't think is enough of a reason to support owning the shares. We estimate $15 is the best-case scenario on a takeout (2x EV/Rev). We think the risk/reward supports an Underweight rating and $7 target."

Allscripts Healthcare Solutions closed at $12.26 on Thursday.

Latest Ratings for MDRX

DateFirmActionFromTo
Aug 2015Argus ResearchUpgradesHoldBuy
Jun 2015OppenheimerInitiates Coverage onPerform
Apr 2015Piper JaffrayUpgradesUnderweightNeutral

View More Analyst Ratings for MDRX
View the Latest Analyst Ratings

Posted-In: Piper JaffrayAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (MDRX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters